magnesium sulfate has been researched along with Leukomalacia, Periventricular in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (28.57) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 5 (35.71) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Beltempo, M; Bertelle, V; Boucorian, I; Dahlgren, L; Lemyre, B; Pelausa, E; Rizzolo, A; Shah, PS; St Hilaire, M | 1 |
| Bhutada, A; Brown, A; Egbert, NM; Haberman, S; Minkoff, H; Narasimhulu, D; Rastogi, S; Rojas, M | 1 |
| Asou, H; Fujii, T; Ichinose, M; Imada, S; Iriyama, T; Kamei, Y; Seyama, T; Toshimitsu, M | 1 |
| Ancel, PY; Benhammou, V; d'Ercole, C; Delorme, P; Foix-L'Hélias, L; Gire, C; Goffinet, F; Kayem, G; Lorthe, E; Marchand-Martin, L; Sentilhes, L; Subtil, D; Torchin, H; Winer, N | 1 |
| Bulas, D; Caritis, SN; Carpenter, MW; DiPietro, M; Dudley, D; Hankins, GD; Hirtz, DG; Iams, JD; Malone, FD; Mercer, BM; O'Sullivan, MJ; Peaceman, AM; Ramin, SM; Reddy, UM; Rouse, DJ; Seibert, J; Sorokin, Y; Thorp, JM; Varner, MW; Wapner, RJ; Weiner, SJ | 1 |
| Matsuda, Y; Mitani, M; Shimada, E | 1 |
| Itakura, A; Matsuzawa, K; Mizutani, S; Murata, Y; Okumura, A; Wakai, K | 1 |
| Bénichou, J; Eurin, D; Hellot, MF; Lévêque, C; Marpeau, L; Marret, S; Zupan-Simunek, V | 1 |
| Astruc, D; Bénichou, J; Bruel, H; Cambonie, G; Delaporte, B; Follet-Bouhamed, C; Guillois, B; Marpeau, L; Marret, S; Pinquier, D; Zupan-Simunek, V | 1 |
| Allred, EN; Hegyi, T; Hiatt, M; Kuban, K; Leviton, A; Paneth, N; Reuss, ML; Sanocka, U; Shahrivar, F; Susser, M; Van Marter, LJ | 1 |
| FineSmith, RB; Fish, I; Kahn, A; Roche, K; Shen, C; Walsh, KK; Yellin, PB; Zeglis, M | 1 |
| Volpe, JJ | 1 |
| Canterino, JC; Figueroa, R; Klein, SA; Tejani, NA; Verma, UL; Visintainer, PF | 1 |
| Besinger, RE; Dambrosia, J; Gianopoulos, JG; Lee, KS; Mittendorf, R; Pryde, PG; Tomich, PG | 1 |
1 review(s) available for magnesium sulfate and Leukomalacia, Periventricular
| Article | Year |
|---|---|
Brain injury in the premature infant. Neuropathology, clinical aspects, pathogenesis, and prevention.
Topics: Brain Diseases; Cell Death; Cerebral Hemorrhage; Cerebral Infarction; Cerebrovascular Circulation; Free Radical Scavengers; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Leukomalacia, Periventricular; Magnesium Sulfate; Oligodendroglia; Spectroscopy, Near-Infrared; Tocolytic Agents | 1997 |
5 trial(s) available for magnesium sulfate and Leukomalacia, Periventricular
| Article | Year |
|---|---|
Antenatal Magnesium and Cerebral Palsy in Preterm Infants.
Topics: Cerebral Hemorrhage; Cerebral Palsy; Cerebral Ventricles; Child, Preschool; Cohort Studies; Electroencephalography; Female; Gestational Age; Humans; Infant; Infant, Newborn; Infant, Premature; Leukomalacia, Periventricular; Magnesium Sulfate; Male; Maternal Exposure; Neuroprotective Agents; Pregnancy; Ultrasonography | 2015 |
Magnesium sulphate given before very-preterm birth to protect infant brain: the randomised controlled PREMAG trial*.
Topics: Adult; Cerebral Palsy; Female; Humans; Infant Mortality; Infant, Newborn; Infant, Premature; Infusions, Intravenous; Leukomalacia, Periventricular; Magnesium Sulfate; Obstetric Labor, Premature; Pregnancy; Pregnancy Outcome; Tocolytic Agents | 2007 |
[Effect of magnesium sulphate on mortality and neurologic morbidity of the very-preterm newborn (of less than 33 weeks) with two-year neurological outcome: results of the prospective PREMAG trial].
Topics: Adult; Cerebral Palsy; Female; Humans; Infant Mortality; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Leukomalacia, Periventricular; Longitudinal Studies; Magnesium Sulfate; Male; Morbidity; Nervous System Diseases; Obstetric Labor, Premature; Pregnancy; Pregnancy Outcome; Prospective Studies; Tocolytic Agents; Treatment Outcome | 2008 |
Effect of magnesium sulfate on the development of cystic periventricular leukomalacia in preterm infants.
Topics: Anticonvulsants; Birth Weight; Cysts; Female; Humans; Infant, Newborn; Infant, Premature; Leukomalacia, Periventricular; Magnesium Sulfate; Pre-Eclampsia; Predictive Value of Tests; Pregnancy; Retrospective Studies; Risk Factors | 1997 |
Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants.
Topics: Adult; Cerebral Hemorrhage; Cerebral Palsy; Female; Fetal Blood; Humans; Infant Mortality; Infant, Newborn; Labor, Obstetric; Leukomalacia, Periventricular; Magnesium; Magnesium Sulfate; Obstetric Labor, Premature; Pregnancy; Prenatal Care; Risk Factors; Tocolytic Agents | 2002 |
8 other study(ies) available for magnesium sulfate and Leukomalacia, Periventricular
| Article | Year |
|---|---|
Cumulative effect of evidence-based practices on outcomes of preterm infants born at <29 weeks' gestational age.
Topics: Adrenal Cortex Hormones; Anticonvulsants; Body Temperature; Canada; Cerebral Intraventricular Hemorrhage; Constriction; Evidence-Based Medicine; Female; Humans; Infant, Extremely Premature; Infant, Newborn; Leukomalacia, Periventricular; Logistic Models; Magnesium Sulfate; Male; Multivariate Analysis; Perinatal Death; Pregnancy; Prenatal Care; Retrospective Studies; Severity of Illness Index; Time Factors; Umbilical Cord | 2020 |
Maternal magnesium therapy, neonatal serum magnesium concentration and immediate neonatal outcomes.
Topics: Adult; Case-Control Studies; Cerebral Intraventricular Hemorrhage; Dose-Response Relationship, Drug; Female; Gestational Age; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infusions, Intravenous; Leukomalacia, Periventricular; Magnesium; Magnesium Sulfate; Male; Neuroprotective Agents; Pregnancy; Retrospective Studies; Tocolytic Agents; Young Adult | 2017 |
Pretreatment with magnesium sulfate attenuates white matter damage by preventing cell death of developing oligodendrocytes.
Topics: Animals; Cell Death; Disease Models, Animal; Hypoxia-Ischemia, Brain; Leukomalacia, Periventricular; Magnesium Sulfate; Male; Neuroprotective Agents; Oligodendroglia; Rats; Rats, Sprague-Dawley; White Matter | 2018 |
Preterm premature rupture of membranes at 22-25 weeks' gestation: perinatal and 2-year outcomes within a national population-based study (EPIPAGE-2).
Topics: Adrenal Cortex Hormones; Adult; Anti-Bacterial Agents; Bronchopulmonary Dysplasia; Cerebral Intraventricular Hemorrhage; Cerebral Palsy; Cesarean Section; Child, Preschool; Enterocolitis, Necrotizing; Female; Fetal Membranes, Premature Rupture; Fetal Mortality; Fetal Viability; France; Gestational Age; Humans; Infant; Infant, Extremely Premature; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Labor, Obstetric; Leukomalacia, Periventricular; Magnesium Sulfate; Patient Transfer; Perinatal Mortality; Pregnancy; Pregnancy Trimester, Second; Prenatal Care; Retinopathy of Prematurity; Stillbirth; Survival Rate; Tocolysis; Tocolytic Agents | 2018 |
Short- and long-term outcomes in babies born after antenatal magnesium treatment.
Topics: Case-Control Studies; Cerebral Hemorrhage; Cerebral Palsy; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Leukomalacia, Periventricular; Magnesium Sulfate; Pregnancy; Pregnancy Outcome; Tocolysis; Tocolytic Agents; Treatment Outcome | 2011 |
Possible antenatal and perinatal related factors in development of cystic periventricular leukomalacia.
Topics: Apgar Score; Case-Control Studies; Causality; Cerebral Palsy; Chorioamnionitis; Comorbidity; Female; Gestational Age; Humans; Indomethacin; Infant, Newborn; Leukomalacia, Periventricular; Magnesium Sulfate; Multivariate Analysis; Pre-Eclampsia; Pregnancy; Premature Birth; Prenatal Exposure Delayed Effects; Retrospective Studies; Risk Assessment; Umbilical Cord | 2005 |
Maternal receipt of magnesium sulfate does not seem to reduce the risk of neonatal white matter damage.
Topics: Adrenal Cortex Hormones; Brain; Cerebral Hemorrhage; Cerebral Palsy; Confounding Factors, Epidemiologic; Echoencephalography; Female; Humans; Hypertension; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Leukomalacia, Periventricular; Logistic Models; Magnesium Sulfate; Odds Ratio; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Prospective Studies | 1997 |
Maternal magnesium sulfate and the development of neonatal periventricular leucomalacia and intraventricular hemorrhage.
Topics: Anticonvulsants; Cerebral Hemorrhage; Female; Humans; Incidence; Infant, Newborn; Infant, Premature, Diseases; Leukomalacia, Periventricular; Magnesium Sulfate; Pregnancy; Pregnancy Complications; Retrospective Studies; Severity of Illness Index; Tocolytic Agents | 1999 |